Cytoplasmic immunoglobulin content in multiple myeloma
The Journal of Clinical Investigation
|August 1, 1985
Summary
Cytoplasmic immunoglobulin (CIg) staining accurately identifies multiple myeloma subtypes and detects previously unrecognized, chemotherapy-resistant plasma cells. This method enhances diagnosis and treatment strategies for refractory myeloma patients.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Multiple myeloma is a plasma cell malignancy.
- Accurate subtyping and identification of refractory disease are crucial for effective treatment.
Purpose of the Study:
- To evaluate the utility of flow cytometric analysis of cytoplasmic immunoglobulin (CIg) content in diagnosing and characterizing multiple myeloma.
- To identify potential markers for chemotherapy resistance.
Main Methods:
- Flow cytometry was used to analyze DNA and cytoplasmic immunoglobulin (CIg) content in bone marrow cells from 82 multiple myeloma patients.
- Propidium iodide and direct immunofluorescence assays were employed.
- Results were compared with immunoelectrophoresis findings.
Main Results:
- CIg staining showed conformity with immunoelectrophoresis in immunoglobulin type for most patients.
- Previously unrecognized plasma cells with low RNA content were identified in 14 patients, all resistant to chemotherapy.
- CIg analysis identified more patients with treatment-refractory myeloma.
Conclusions:
- CIg staining is a reliable method for immunoglobulin typing in multiple myeloma.
- CIg analysis can identify patients with treatment-refractory disease by detecting low RNA content plasma cells.
- This method improves the identification of refractory multiple myeloma.
More Related Videos
Related Concept Videos
02:33Distribution of Cytoplasmic Content
3.3K
Cytokinesis segregates a cell’s chromosomes and organelles into its daughter cells. Organelles divide and grow prior to cell division but cannot be synthesized de novo; therefore, cells must receive at least one copy of each organelle to survive. Currently, many of the details of how the organelles are distributed are not yet fully elucidated.
Distribution of cytoplasmic determinants
The cytoplasm contains various organelles, as well as salts, proteins, and water. The distribution of...
Distribution of cytoplasmic determinants
The cytoplasm contains various organelles, as well as salts, proteins, and water. The distribution of...
3.3K
01:15Transcytosis of IgG
3.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
01:31Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
01:31Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
01:20Immunoprecipitation
5.6K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.6K
01:22Immunocytochemistry and Immunohistochemistry
11.6K
Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
These...
11.6K